Illumina TruSight Cancer Panel
「Illumina TruSight Cancer Panel」熱門搜尋資訊
「Illumina TruSight Cancer Panel」文章包含有：「TruSightCancer」、「TruSightCancer」、「TruSightCancer–VirtualPanels」、「TruSightHereditaryCancerPanel」、「TruSightHereditaryCancerPanelDataSheet」、「TruSightHereditaryCancerPanel」、「TruSightRNAPan」、「TruSightSequencingPanels」、「TruSight®CancerSequencingPanel」
查看更多
TruSight Cancer
https://sapac.illumina.com
TruSight Cancer. These expert-defined sequencing research panels target 94 genes and 284 SNPs associated with a predisposition towards various cancers.
TruSight Cancer
https://www.illumina.com.cn
TruSight Cancer测序panel提供靶向经过鉴定的目标区域的定制寡核苷酸。提供了足以进行四次富集反应的产品。TruSight Cancer与 TruSight Rapid Capture兼容。
TruSight Cancer – Virtual Panels
https://repositorio.insa.pt
Aims/Context: Next Generation Sequencing (NGS) revolutionized human genetic diagnosis leading to a dramatic improvement at many levels. NGS multigene panels ...
TruSight Hereditary Cancer Panel
https://sapac.illumina.com
The TruSight Hereditary Cancer Panel is a targeted sequencing panel designed to assess germline mutations across 113 genes and 125 single nucleotide ...
TruSight Hereditary Cancer Panel Data Sheet
https://semmelweis.hu
Comprehensive content for assessing germline mutations. Panel includes 113 expert-selected genes associated with hereditary cancerpredisposition.
TruSight Hereditary Cancer Panel
https://www.illumina.com.cn
广泛的panel包括113个与遗传性癌症易感性相关的基因 · 简单的实验方案可实现快速灵活的文库制备和富集 · 兼容所有Illumina台式测序系统，每次运行的样本通量范围为2至256个 ...
TruSight RNA Pan
https://sapac.illumina.com
The TruSight RNA Pan-Cancer Panel offers in-depth and cost-effective assessment of cancer-related RNA transcripts in limited and degraded samples on a benchtop ...
TruSight Sequencing Panels
https://www.illumina.com
TruSight Hereditary Cancer Panel. Targeted sequencing panel that assesses germline mutations across 113 genes and 125 SNPs associated with genetic cancer risk ...
TruSight® Cancer Sequencing Panel
https://www.illumina.com
The TruSight Cancer Sequencing Panel was developed in collaboration with Professor Nazneen Rahman and team at The Institute of Cancer. Research (ICR), London.